352 related articles for article (PubMed ID: 15500614)
1. Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.
Williams LM; Ricchetti G; Sarma U; Smallie T; Foxwell BM
Immunology; 2004 Nov; 113(3):281-92. PubMed ID: 15500614
[TBL] [Abstract][Full Text] [Related]
2. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells.
Jurlander J; Lai CF; Tan J; Chou CC; Geisler CH; Schriber J; Blumenson LE; Narula SK; Baumann H; Caligiuri MA
Blood; 1997 Jun; 89(11):4146-52. PubMed ID: 9166857
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
Tanuma N; Shima H; Nakamura K; Kikuchi K
Blood; 2001 Nov; 98(10):3030-4. PubMed ID: 11698287
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways.
Ahmed ST; Ivashkiv LB
J Immunol; 2000 Nov; 165(9):5227-37. PubMed ID: 11046056
[TBL] [Abstract][Full Text] [Related]
6. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.
Williams L; Bradley L; Smith A; Foxwell B
J Immunol; 2004 Jan; 172(1):567-76. PubMed ID: 14688368
[TBL] [Abstract][Full Text] [Related]
7. HTLV-1 cell lines differ in constitutively activated signaling pathways that can be altered by cytokine exposure.
Liang W; Hague B; Zhao T; Kindt TJ
Virology; 2001 Nov; 290(1):91-8. PubMed ID: 11883009
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion.
Lee IH; Li WP; Hisert KB; Ivashkiv LB
J Exp Med; 1999 Nov; 190(9):1263-74. PubMed ID: 10544198
[TBL] [Abstract][Full Text] [Related]
9. STAT3-mediated anti-inflammatory signalling.
Murray PJ
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1028-31. PubMed ID: 17073743
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 signal transduction and lymphocyte function.
Horn F; Henze C; Heidrich K
Immunobiology; 2000 Aug; 202(2):151-67. PubMed ID: 10993289
[TBL] [Abstract][Full Text] [Related]
11. IL-2 overcomes the unresponsiveness but fails to reverse the regulatory function of antigen-induced T regulatory cells.
Anderson PO; Sundstedt A; Yazici Z; Minaee S; O'Neill EJ; Woolf R; Nicolson K; Whitley N; Li L; Li S; Wraith DC; Wang P
J Immunol; 2005 Jan; 174(1):310-9. PubMed ID: 15611254
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
13. Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements.
Lai CF; Ripperger J; Morella KK; Jurlander J; Hawley TS; Carson WE; Kordula T; Caligiuri MA; Hawley RG; Fey GH; Baumann H
J Biol Chem; 1996 Jun; 271(24):13968-75. PubMed ID: 8662928
[TBL] [Abstract][Full Text] [Related]
14. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.
O'Farrell AM; Liu Y; Moore KW; Mui AL
EMBO J; 1998 Feb; 17(4):1006-18. PubMed ID: 9463379
[TBL] [Abstract][Full Text] [Related]
15. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.
Dahmen H; Horsten U; Küster A; Jacques Y; Minvielle S; Kerr IM; Ciliberto G; Paonessa G; Heinrich PC; Müller-Newen G
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):695-702. PubMed ID: 9560294
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10.
Crepaldi L; Gasperini S; Lapinet JA; Calzetti F; Pinardi C; Liu Y; Zurawski S; de Waal Malefyt R; Moore KW; Cassatella MA
J Immunol; 2001 Aug; 167(4):2312-22. PubMed ID: 11490020
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of IL-10 activity and signaling by IFN-gamma.
Herrero C; Hu X; Li WP; Samuels S; Sharif MN; Kotenko S; Ivashkiv LB
J Immunol; 2003 Nov; 171(10):5034-41. PubMed ID: 14607900
[TBL] [Abstract][Full Text] [Related]
18. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression.
Carl VS; Gautam JK; Comeau LD; Smith MF
J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058
[TBL] [Abstract][Full Text] [Related]
19. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages.
Yasukawa H; Ohishi M; Mori H; Murakami M; Chinen T; Aki D; Hanada T; Takeda K; Akira S; Hoshijima M; Hirano T; Chien KR; Yoshimura A
Nat Immunol; 2003 Jun; 4(6):551-6. PubMed ID: 12754507
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Stat3 in interleukin-6-induced IgM production in a human B-cell line.
Faris M; Kokot N; Stahl N; Nel AE
Immunology; 1997 Mar; 90(3):350-7. PubMed ID: 9155640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]